Nano-X Imaging Ltd. header image

Nano-X Imaging Ltd.

NNOX

Equity

ISIN IL0011681371 / Valor 56410599

NASDAQ (2026-02-20)
USD 2.43+1.67%

Nano-X Imaging Ltd.
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Nano-X Imaging Ltd. is a NASDAQ-listed medical imaging company dedicated to making advanced diagnostic technologies more affordable and accessible, thereby promoting preventive healthcare. The company leverages its proprietary digital X-ray source and artificial intelligence to offer a comprehensive ecosystem that includes the Nanox.ARC Digital Tomosynthesis system, which provides cost-effective and user-friendly imaging, and Nanox.AI, which enhances CT scans by identifying early signs of chronic diseases. Additionally, Nano-X provides Nanox.CLOUD, a cloud-based platform for managing and analyzing imaging data, and Nanox.MARKETPLACE, a decentralized service that connects users with radiology and cardiology experts through teleradiology services. By integrating these technologies, Nano-X aims to streamline the imaging process from scan to diagnosis, improve early detection and treatment, and ultimately enhance health outcomes on a global scale.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-62.0%1Y
-69.5%3Y
-95.7%5Y

Performance

68.5%1Y
88.6%3Y
86.7%5Y

Volatility

Market cap

159 M

Market cap (USD)

Daily traded volume (Shares)

1,265,536

Daily traded volume (Shares)

1 day high/low

7.605 / 7

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Viking Therapeutics Inc
Viking Therapeutics Inc Viking Therapeutics Inc Valor: 24839858
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.23%USD 31.03
CureVac N.V.
CureVac N.V. CureVac N.V. Valor: 56537572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 4.66
ALX Oncology Holdings Inc
ALX Oncology Holdings Inc ALX Oncology Holdings Inc Valor: 55754366
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.77%USD 2.45
ACELYRIN INC
ACELYRIN INC ACELYRIN INC Valor: 126441937
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 2.27
Stride Inc
Stride Inc Stride Inc Valor: 58406765
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.43%USD 82.58
Biohaven Research Ltd
Biohaven Research Ltd Biohaven Research Ltd Valor: 121902526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.40%USD 11.23
Cooper Companies Inc
Cooper Companies Inc Cooper Companies Inc Valor: 132951296
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.47%USD 84.07
Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals Inc Amneal Pharmaceuticals Inc Valor: 41368351
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.68%USD 14.50
Waystar Holding Corp
Waystar Holding Corp Waystar Holding Corp Valor: 130358792
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.79%USD 25.07
Bio-Rad Laboratories, Inc. Class B
Bio-Rad Laboratories, Inc. Class B Bio-Rad Laboratories, Inc. Class B Valor: 912794
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 261.83